Current Standards of Care in Glioblastoma Therapy
Author:
Publisher
Codon Publications
Reference230 articles.
1. Epidemiologic and Molecular Prognostic Review of Glioblastoma
2. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
4. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
5. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Cited by 238 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Temozolomide cocrystal forms with enhanced dissolution, stability and biological activity towards Glioblastoma;Journal of Molecular Structure;2024-10
2. The Patterns of Failure and Prognostic Impact of Tumor Location in Patients Undergoing Reirradiation for Glioblastoma;Cureus;2024-09-06
3. Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma;Molecular Therapy: Oncology;2024-09
4. A novel trifluoromethyl quinoline derivative targeting SGK1 inducing autophagy and apoptosis via regulating mTOR/FOXO3a pathway in glioblastoma;Arabian Journal of Chemistry;2024-09
5. Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane;Drug Resistance Updates;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3